Journal ArticleOPEN ACCESS

Exceptional Response to Second-Line Gemcitabine/Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma

  • Bukhari N
  • Abdalla K
  • Ibnshamsa F
  • et al.
Cureus (2021)
DOI: 10.7759/cureus.18756
N/ACitations
Citations of this article
3Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Bukhari, N., Abdalla, K., Ibnshamsa, F., Alselwi, W., Al-Shakir, S., & Alqahtani, M. (2021). Exceptional Response to Second-Line Gemcitabine/Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma. Cureus. https://doi.org/10.7759/cureus.18756

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free